SEARCH

SEARCH BY CITATION

References

  • Attebo K, Mitchell P & Smith W (1996): Visual acuity and the causes of visual loss in Australia: the Blue Mountains Eye Study. Ophthalmology 103: 357364.
  • Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA & Giust MJ (2006): Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 113: 363372.
  • Bartlett H, Stainer L, Singh S, Eperjesi F & Howels O (2010): Clinical evaluation of the MPS 9000 Macular Pigment Screener. Br J Ophthalmol 94: 753756.
  • Beatty S, Koh HH, Carden D & Murray IJ (2000): Macular pigment optical density measurement: a novel compact instrument. Ophthalmic Physiol Opt 20: 105111.
  • Beatty S, Murray IJ, Henson DB, Carden D, Koh HH & Boulton ME (2001): Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest Ophthalmol Vis Sci 42: 439446.
  • Berendschot TJM, DeLint PJ & van Norren D (2003): Fundus reflectance—historical and present ideas. Prog Retin Eye Res 22: 171200.
  • Bernstein PS, Delori FC, Richer S, Van Kuijk FJM & Wenzel AJ (2010): The value of measurement of macular carotenoid pigment optical densities and distributions in age-related macular degeneration and other retinal disorders. Vision Res 50: 716728.
  • Bland J & Altman D (1986): Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1: 307310.
  • Bone RA & Sparrock JM (1971): Comparison of macular pigment densities in human eyes. Vision Res 11: 10571064.
  • Bone RA, Landrum JT & Cains A (1992): Optical density spectra of the macular pigment in vivo and in vitro. Vision Res 32: 105110.
  • Bone RA, Landrum JT, Frieded LM, Gomez CM, Kilburn MD, Menendez E, Vidal I & Wang W (1997): Distribution of lutein and zeaxanthin stereoisomers in the human retina. Exp Eye Res 64: 211218.
  • Bone RA, Landrum JT, Mayne ST, Gomez CM, Tibor SE & Twaroska EE (2001): Macular pigment in donor eyes with and without AMD: a case-control study. Invest Ophthalmol Vis Sci 42: 235240.
  • Bone RA, Landrum JT, Guerra LH & Ruiz CA (2003): Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans. J Nutr 133: 992998.
  • Ciulla TA, Danis RP & Harris A (1988): Age-related macular degeneration: a review of experimental treatments. Surv Ophthalmol 43: 134146.
  • Ciulla TA, Curran-Celantano J, Cooper DA, Hammond BR, Danis RP, Pratt LM, Riccardi KA & Filloon TG (2001): Macular pigment optical density in a midwestern sample. Ophthalmology 108: 730737.
  • Connolly E, Beatty S, Thurnham DI, Loughman J, Howard AN, Stack J & Nolan JM (2010): Augmentation of macular pigment following supplementation with all three macular carotenoids: an exploratory study. Curr Eye Res 35: 335351.
  • Dietzel M, Zeimer M, Heimes B, Claes B, Pauleikhoff D & Werner Hense H (2011): Determinants of macular pigment optical density and its relation to age-related maculopathy – results from the Muenster Aging and Retina Study (MARS). Invest Ophthalmol Vis Sci 52: 34523457.
  • Eye Disease Case-Control Study Group. (1993): Anti-oxidant status and neovascular age-related macular degeneration. Arch Ophthalmol 111(1): 104109.
  • Friedman DS, O’Colmain BJ, Munoz B et al. (2004): Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122: 564572.
  • Gallaher MM, Todda WA, Harrisa TL, Kenyonc E, Harris T, Johnsone KC, Satterfielde S & Kritchevskye SB (2007): Estimation of macular pigment optical density in the elderly: test-retest variability and effect of optical blur in pseudophakic subjects. Vision Res 47: 12531259.
  • Hammond BR, Fuld K & Curran Celesteno J (1995): Macular pigment density in monozygotic twins. Invest Ophthalmol Vis Sci 36: 25312541.
  • Hammond BR, Wooten BR & Snodderly DM (1997): Individual variations in the spatial profile of human macular pigment. J Opt Soc Am 14: 11871196.
  • Hammond BR, Wooten BR & Smollon B (2005): Assessment of the validity of in vivo methods of measuring human macular pigment optical density. Optom Vis Sci 82: 387404.
  • Hommel B, Li KZH & Li S-C (2004): Visual search across the life span. Dev Psychol 40: 545558.
  • Johnson EJ, Neuringer M, Russell RM & Schalch W & Snodderly DM (2005): Nutritional manipulation of primate retinas, 111: effects of lutein or zeaxanthin supplementation on adipose tissue and retina of xanthophylls free monkeys. Invest Ophthalmol Vis Sci 46: 692702.
  • de Kinkelder R, van der Veen RLP, Verbaak FD, Faber DJ, van Leeuwen TG, Berendschot TTJM (2011): Macular pigment optical density measurements: evaluation of a device using heterochromatic flicker photometry. EYE 25: 105112.
  • Leibowitz HM, Kreuger DE, Maunder LR et al. (1980): The framingham eye study monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration and visual acuity in a general population of 2631 adults 1973–1975. Surv Ophthalmol 24: 335610.
  • Loane E, Stack J, Beatty S & Nolan JM (2007): Measurement of macular pigment optical density using two different heterochromatic flicker photometers. Curr Eye Res 32: 555564.
  • Loughman J, Akkalli M, Beatty S et al. (2010): The relationship between macular pigment and visual performance. Vision Res 50: 12491256.
  • Macular Photocoagulation Study Group (1993): Five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization. Arch Ophthalmol 111: 11891199.
  • Madden DJ & Allen PA (1995): Aging and the speed/accuracy relation in visual search: evidence for an accumulator model. Optom Vis Sci 72: 210216.
  • Makridaki M, Carden D & Murray IJ (2009): Macular pigment measurement in clinics: controlling the effect of the ageing media. Ophthal Physiol Opt 29: 338344.
  • Murray IJ, Carden D & Makridaki M (2011): The repeatability of the MPS 9000 macular pigment screener. Br J Ophthalmol 95: 431432.
  • Nolan JM, Stringham JM, Beatty S & Snodderly DM (2008): Spatial profile of macular pigment and its relationship to foveal architecture. Invest Ophthalmol Vis Sci 49: 21342142.
  • Pease PL, Adams AJ & Nuccio E (1987): Optical-density of human macular pigment. Vision Res 27: 705710.
  • Porciatti V, Fiorentini A, Morrone MC & Burr DC (1999): The effects of ageing on reaction times to motion onset. Vision Res 39: 21572164.
  • Richer S, Stiles W, Statkute L et al. (2004): Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry 75: 216230.
  • Rougier MB & Delyfer MN & Korobelnik JF (2008): Measuring macular pigment in vivo. J Fr Ophtalmol 31: 445453.
  • Seddon JM, Ajani UA, Sperduto RD et al. (1994): Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case Control Study Group. JAMA 272: 14551456.
  • Snodderly DM (1995): Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. Am J Clin Nutr 62: 14481461.
  • Snodderly DM, Auran JD & Delori FC (1984a): The macular pigment. 2. Spatial distribution in primate retinas. Invest Ophthalmol Vis Sci 25: 674685.
  • Snodderly DM, Brown PK, Delori FC & Auran J (1984b): The macular pigment. I. Absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas. Invest Ophthalmol Vis Sci 25: 660673.
  • Snodderly DM, Mares JA, Wooten BR, Oxton L, Gruber M & Ficek T (2004): Macular pigment measurement by heterochromatic flicker photometry in older subject: the carotenoids & age-related eye disease study. Invest Ophthalmol Vis Sci 45: 531538.
  • Stringham JM, Hammond BR, Nolan JM, Wooten BR & Mammen A (2008): The utility of using customized heterochromatic flicker photometry (cHFP) to measure macular pigment in patients with age-related macular degeneration. Exp Eye Res 87: 445453.
  • van der Veen RLP, Berdenshot TT, Hendrikse F, Cardeen D, Makridaki M & Murray IJ (2009): A new desktop instrument for measuring macular pigment optical density based on a novel technique for setting flicker thresholds. Ophthalmic Physiol Opt 29: 127137.
  • Wooten BR, Hammond BR, Land RI & Snodderly DM (1999): A practical method for measuring macular pigment optical density. Invest Ophthalmol Vis Sci 40: 24812489.